Retatrutide (10mg/20 mg)

Retatrutide– Research Peptide

GLP-3 is a multi-receptor agonist peptide studied for its activity across key metabolic pathways. It is designed to interact with receptors associated with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon, making it a compound of significant interest in advanced metabolic and energy regulation research.

In laboratory settings, Retatrutide is investigated for its potential effects on appetite signaling, energy expenditure, and glucose metabolism. Its multi-pathway mechanism allows researchers to explore how combined receptor activation may influence metabolic efficiency, fat utilization, and overall energy balance in experimental models.

Preclinical and investigational studies have examined Retatrutide in relation to body composition, insulin sensitivity, and weight regulation pathways. It is also studied for its potential role in hepatic metabolism and lipid regulation, as well as its broader implications in metabolic health research.

Key Research Areas:

Multi-receptor metabolic pathway activation (GLP-1, GIP, glucagon)

Appetite regulation and energy balance

Glucose metabolism and insulin sensitivity

Fat metabolism and body composition studies

Hepatic and lipid metabolism research

Important Notice:

Supplied by Analogue Peptides, Retatrutide is a research-grade peptide intended strictly for research only. It is not a cosmetic, supplement, or medication, and is not intended for human consumption, therapeutic application, or clinical use.

Triple agonist peptide, GLP-1 GIP glucagon research compound, metabolic regulation peptide, weight management research, fat metabolism studies, advanced peptide research, laboratory research use only.

All compounds are supplied as lyophilized (freeze-dried) powder to support stability during storage and shipping. Products are intended for laboratory research purposes only.